Covid-19 Antivirals
Vaccines remain the primary defence against COVID-19, but early in December 2021 the UK Government announced that it had also made available other new treatment options for COVID-19 for eligible groups of patients.
Thousands of the UK’s most vulnerable people will be among the first in the world to access cutting-edge antiviral and antibody treatments. These new treatments are used in the earliest stages of infection and often taken at home. They must be administered as soon as possible after a confirmed COVID-19 positive PCR test has been received.
CPE Antiviral treatments for COVID-19
NHS Letter to patients: Important information about treatments for Covid
COVID-19 antibody and antiviral treatments
Summary of Product Characteristics for Paxlovid
How and when to take Paxlovid – NHS (www.nhs.uk)
Patient Information Leaflet for Paxlovid – GOV.UK (www.gov.uk)
HW ICB COVID-19 Treatment Pathway Update 26 June 2023
HWICS Pathway COVID-19 Tx Non-hosp v6 14062023_pages1-3
(please note: the contact information contained on pages 4-5 of the above document has been removed for privacy issues. If you need to obtain a copy of the original file, which was e-mailed to pharmacies previously, please contact us on ahwlpc@gmail.com)
This service is provided by the same pharmacies who are signed up to provide the Palliative Care Service.
